Similar articles for PMID: 23042936

Year	Number of Results
2002	1
2003	1
2006	1
2007	1
2008	4
2009	3
2010	3
2011	12
2012	24
2013	12
2014	5
2015	9
2016	5
2017	2
2018	1
2019	1
2020	1
2021	1
2022	1
2024	0

1

Role of SPECT/CT, versus traditional practices, in individualizing treatment of thyroid carcinoma.

Basu S, Abhyankar A. Basu S, et al. J Nucl Med. 2012 Nov;53(11):1819; author reply 1819-1820. doi: 10.2967/jnumed.112.110007. Epub 2012 Oct 5. J Nucl Med. 2012. PMID: 23042936 Free article. No abstract available.

2

Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.

Maruoka Y, Abe K, Baba S, Isoda T, Sawamoto H, Tanabe Y, Sasaki M, Honda H. Maruoka Y, et al. Radiology. 2012 Dec;265(3):902-9. doi: 10.1148/radiol.12112108. Epub 2012 Sep 25. Radiology. 2012. PMID: 23012466

3

Role of SPECT/CT in differentiated thyroid cancer.

Barwick TD, Dhawan RT, Lewington V. Barwick TD, et al. Nucl Med Commun. 2012 Aug;33(8):787-98. doi: 10.1097/MNM.0b013e3283550257. Nucl Med Commun. 2012. PMID: 22669053 Review.

4

[Diagnostics and treatment of differentiated thyroid cancer using nuclear medicine].

Morsing A, Bogsrud TV. Morsing A, et al. Ugeskr Laeger. 2012 Jun 25;174(26):1813-6. Ugeskr Laeger. 2012. PMID: 22735115 Danish.

5

[Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].

Serrano Vicente J, Infante Torre JR, Rayo Madrid JI, García Bernardo L, Domínguez Grande ML, Durán Barquero C, Sánchez Sánchez R. Serrano Vicente J, et al. Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug;31(4):229-30. doi: 10.1016/j.remn.2012.01.006. Epub 2012 May 6. Rev Esp Med Nucl Imagen Mol. 2012. PMID: 22980131 Spanish. No abstract available.

6

Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.

Wakabayashi H, Nakajima K, Fukuoka M, Inaki A, Nakamura A, Kayano D, Kinuya S. Wakabayashi H, et al. Ann Nucl Med. 2011 Nov;25(9):609-15. doi: 10.1007/s12149-011-0513-z. Epub 2011 Jul 2. Ann Nucl Med. 2011. PMID: 21725630

7

Role of [(18)F]-fluorodeoxy-D-glucose positron emission tomography and computed tomography in the early detection of persistent/recurrent thyroid carcinoma in intermediate-to-high risk patients following initial radioactive iodine ablation therapy.

Kim MH, O JH, Ko SH, Bae JS, Lim DJ, Kim SH, Baek KH, Lee JM, Kang MI, Cha BY, Lee KW. Kim MH, et al. Thyroid. 2012 Feb;22(2):157-64. doi: 10.1089/thy.2011.0177. Epub 2012 Jan 6. Thyroid. 2012. PMID: 22224820

8

Radioiodine scintigraphy with SPECT/CT: an important diagnostic tool for thyroid cancer staging and risk stratification.

Avram AM. Avram AM. J Nucl Med. 2012 May;53(5):754-64. doi: 10.2967/jnumed.111.104133. J Nucl Med. 2012. PMID: 22550280 Free article. Review.

9

Should all patients with differentiated thyroid carcinoma undergo 131I SPECT-CT scanning rather than 131I whole-body scanning?

Al Balooshi B, Vinjamuri S. Al Balooshi B, et al. Nucl Med Commun. 2015 Jun;36(6):549-52. doi: 10.1097/MNM.0000000000000277. Nucl Med Commun. 2015. PMID: 25906202 No abstract available.

10

A proposition for the use of radioiodine in WDTC management.

Bourgeois P. Bourgeois P. J Nucl Med. 2009 Feb;50(2):328-9; author reply 329-30. doi: 10.2967/jnumed.108.057141. Epub 2009 Jan 21. J Nucl Med. 2009. PMID: 19164221 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

79 results

Results by year